Media Coverage

Argenta appoints chief executive as Doug Cleverly steps back


Mar 19, 2019 -
By Sian Lazell

Contract manufacturing and research organization Argenta has named Ben Russell chief executive of the firm.

Dr Russell joined New Zealand-based Argenta in November 2017 as deputy chief executive. He has taken up the new role of chief executive following the decision of founder Doug Cleverly to take a step back from executive leadership of the company.

Dr Russell has a background in banking and agriculture, having previously worked at Heartland Bank and Rabobank New Zealand, as well as Meat and Livestock Australia. He has both a bachelor degree and PhD in wool and animal science from the University of New South Wales.

Dr Cleverly founded Argenta 13 years ago. Despite stepping back from his executive role, he will continue as both a director and shareholder of Argenta. He will also work in a consulting role to back the company’s strategic engagement with customers and product development.

"Argenta has gone through a rapid and exciting period of growth since 2006 when we were a single site contract research and manufacturing organization, primarily focused on the Australasian production animal market," Dr Cleverly said.

"Since then, and in response to burgeoning customer demand, Argenta has grown in every sense of the word – three FDA- and EMA-accredited manufacturing businesses in the US, UK and New Zealand, together with a multi-faceted research and development business, developing and manufacturing animal health products in both companion and food animals and delivering products to our customers in over 40 countries."   

He added: "When we started in 2006 we were a team of 60 operating out of a single facility in South Auckland. Today we’re a team of 430, still anchored in New Zealand but now across the US and the UK. I was particularly proud late in 2018 when Argenta won the inaugural Animal Pharm Best Services Company award – a fitting recognition of the achievements of our dedicated employees across the world."

Argenta board chairman David Geor commented: "Dr Cleverly's vision, entrepreneurship and passion have been pivotal in leading our team and creating and sustaining Argenta through its startup and growth phases."

Reprinted with permission of Animal Pharm News

Share

Search

Archive

News Releases

Inside the Corridor

KC Animal Health Blog

Investment Forum